A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency
about
More Favorable Metabolic Impact of Three-Times-Weekly versus Daily Growth Hormone Treatment in Naïve GH-Deficient ChildrenThe rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency.Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.Metal-bound claMP Tag inhibits proteolytic cleavage.Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial.
P2860
A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A Randomized Safety and Effica ...... tric Growth Hormone Deficiency
@ast
A Randomized Safety and Effica ...... tric Growth Hormone Deficiency
@en
type
label
A Randomized Safety and Effica ...... tric Growth Hormone Deficiency
@ast
A Randomized Safety and Effica ...... tric Growth Hormone Deficiency
@en
prefLabel
A Randomized Safety and Effica ...... tric Growth Hormone Deficiency
@ast
A Randomized Safety and Effica ...... tric Growth Hormone Deficiency
@en
P2093
P2860
P356
P1476
A Randomized Safety and Effica ...... tric Growth Hormone Deficiency
@en
P2093
Douglas Rogers
Eric Humphriss
Gad B Kletter
George M Bright
Huong Jil Nguyen
Jeffrey L Cleland
Jerome A Moore
Wayne V Moore
P2860
P304
P356
10.1210/JC.2015-3279
P407
P577
2015-12-16T00:00:00Z